Brady W Dougan's most recent trade in Humacyte Inc was a trade of 1,100,000 Common Stock done at an average price of $1.6 . Disclosure was reported to the exchange on Aug. 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Humacyte Inc | Brady W. Dougan | Director | Sale of securities on an exchange or to another person at price $ 1.63 per share. | 18 Aug 2025 | 1,100,000 | 591,685 | - | 1.6 | 1,793,000 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director | Sale of securities on an exchange or to another person at price $ 1.58 per share. | 18 Aug 2025 | 591,685 | 0 | - | 1.6 | 934,862 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director | Sale of securities on an exchange or to another person at price $ 1.83 per share. | 18 Aug 2025 | 549,360 | 1,691,685 | - | 1.8 | 1,005,329 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 1,130,311 | 1,130,311 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Brady Dougan W. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 525 | 2,625 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Brady W. Dougan | Director | Purchase of securities on an exchange or from another person at price $ 4.44 per share. | 19 Nov 2024 | 1,797 | 243,851 | - | 4.4 | 7,979 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director | Sale of securities on an exchange or to another person at price $ 4.44 per share. | 18 Nov 2024 | 811,172 | 2,419,712 | - | 4.4 | 3,601,604 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director | Sale of securities on an exchange or to another person at price $ 4.34 per share. | 18 Nov 2024 | 427,459 | 1,992,253 | - | 4.3 | 1,855,172 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director | Sale of securities on an exchange or to another person at price $ 4.40 per share. | 18 Nov 2024 | 261,369 | 1,730,884 | - | 4.4 | 1,150,024 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director | Sale of securities on an exchange or to another person at price $ 5.23 per share. | 09 Sep 2024 | 288,674 | 3,230,884 | - | 5.2 | 1,509,765 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director | Sale of securities on an exchange or to another person at price $ 5.42 per share. | 09 Sep 2024 | 157,704 | 3,519,558 | - | 5.4 | 854,756 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director | Purchase of securities on an exchange or from another person at price $ 6.55 per share. | 29 Aug 2024 | 1,222 | 242,054 | - | 6.5 | 7,998 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director | Sale of securities on an exchange or to another person at price $ 6.35 per share. | 27 Aug 2024 | 352,112 | 3,677,262 | - | 6.3 | 2,235,911 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director | Sale of securities on an exchange or to another person at price $ 6.47 per share. | 27 Aug 2024 | 277,090 | 4,029,374 | - | 6.5 | 1,792,772 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director | Sale of securities on an exchange or to another person at price $ 6.71 per share. | 27 Aug 2024 | 252,676 | 4,306,464 | - | 6.7 | 1,695,456 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 50,000 | 50,000 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Brady W. Dougan | Director | Sale of securities on an exchange or to another person at price $ 7.09 per share. | 11 Jun 2024 | 282,000 | 4,907,288 | - | 7.1 | 2,000,000 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director | Sale of securities on an exchange or to another person at price $ 7.30 per share. | 11 Jun 2024 | 271,518 | 4,559,140 | - | 7.3 | 1,982,081 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director | Sale of securities on an exchange or to another person at price $ 7.02 per share. | 11 Jun 2024 | 76,630 | 4,830,658 | - | 7.0 | 537,943 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director | Purchase of securities on an exchange or from another person at price $ 6.35 per share. | 04 Jun 2024 | 2,362 | 240,832 | - | 6.4 | 14,999 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director | Purchase of securities on an exchange or from another person at price $ 7.37 per share. | 03 Jun 2024 | 2,050 | 238,470 | - | 7.4 | 15,109 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director | Sale of securities on an exchange or to another person at price $ 7.78 per share. | 31 May 2024 | 716,573 | 5,474,567 | - | 7.8 | 5,574,938 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director | Sale of securities on an exchange or to another person at price $ 7.42 per share. | 31 May 2024 | 190,214 | 5,191,140 | - | 7.4 | 1,411,388 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director | Sale of securities on an exchange or to another person at price $ 8.93 per share. | 31 May 2024 | 93,213 | 5,381,354 | - | 8.9 | 832,392 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director | Sale of securities on an exchange or to another person at price $ 7.28 per share. | 31 May 2024 | 1,852 | 5,189,288 | - | 7.3 | 13,483 | Common Stock |
| Humacyte Inc | W. Brady Dougan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2023 | 803,000 | 803,000 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Brady W. Dougan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2023 | 525 | 2,100 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Brady W. Dougan | Director | Sale of securities on an exchange or to another person at price $ 3.57 per share. | 17 Aug 2023 | 626,979 | 8,793,583 | - | 3.6 | 2,238,315 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director | Sale of securities on an exchange or to another person at price $ 3.39 per share. | 17 Aug 2023 | 602,443 | 8,191,140 | - | 3.4 | 2,042,282 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director | Sale of securities on an exchange or to another person at price $ 3.68 per share. | 17 Aug 2023 | 570,174 | 9,420,562 | - | 3.7 | 2,098,240 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.12 per share. | 15 Jun 2023 | 500,000 | 9,990,736 | - | 3.1 | 1,558,750 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 8,500 | 8,500 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Brady W. Dougan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.60 per share. | 13 Jun 2023 | 4,875,000 | 10,490,736 | - | 2.6 | 12,675,000 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.75 per share. | 25 May 2023 | 2,625,000 | 15,365,736 | - | 2.8 | 7,218,750 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.19 per share. | 01 Mar 2023 | 100,000 | 1,270,240 | - | 1.2 | 119,000 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 100,000 | 162,596 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Brady W. Dougan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.53 per share. | 16 Dec 2022 | 239,538 | 17,990,736 | - | 2.5 | 606,031 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.54 per share. | 15 Dec 2022 | 10,000 | 1,170,240 | - | 2.5 | 25,400 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.84 per share. | 13 Dec 2022 | 330,000 | 18,600,004 | - | 2.8 | 937,200 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.76 per share. | 13 Dec 2022 | 276,304 | 18,323,700 | - | 2.8 | 762,599 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.63 per share. | 13 Dec 2022 | 93,426 | 18,230,274 | - | 2.6 | 245,710 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2022 | 444,500 | 444,500 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Brady W. Dougan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.00 per share. | 15 Sep 2022 | 1,522,500 | 18,930,004 | - | 4 | 6,090,000 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.14 per share. | 15 Sep 2022 | 2,000 | 1,160,240 | - | 4.1 | 8,280 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 8,500 | 8,500 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Brady W. Dougan | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.83 per share. | 23 May 2022 | 10,000 | 1,158,240 | - | 4.8 | 48,300 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.88 per share. | 14 Dec 2021 | 125,000 | 585,161 | - | 8.9 | 1,110,625 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.32 per share. | 14 Dec 2021 | 76,306 | 710,161 | - | 9.3 | 711,553 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 14 Dec 2021 | 75,000 | 510,161 | - | 9 | 675,000 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.80 per share. | 14 Dec 2021 | 23,694 | 786,467 | - | 9.8 | 232,154 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2021 | 8,500 | 8,500 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Brady W. Dougan | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 18,930,004 | 18,930,004 | - | - | Common Stock | |
| Humacyte Inc | Brady W. Dougan | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 10.00 per share. | 26 Aug 2021 | 1,522,500 | 20,452,504 | - | 10 | 15,225,000 | Common Stock |
| Humacyte Inc | Brady W. Dougan | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 1,312,984 | 1,312,984 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Brady W. Dougan | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 1,148,240 | 1,148,240 | - | - | Common Stock | |
| Humacyte Inc | Brady W. Dougan | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 262,596 | 262,596 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Brady W. Dougan | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 262,596 | 262,596 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Brady W. Dougan | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 157,558 | 157,558 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Brady W. Dougan | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 131,298 | 131,298 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Brady W. Dougan | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 17,068 | 17,068 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Brady W. Dougan | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 13,129 | 13,129 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Brady W. Dougan | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 13,129 | 13,129 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Brady W. Dougan | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 1,575 | 1,575 | - | - | Stock Options (right to buy) |